{"id":"https://openalex.org/W2165220936","doi":"https://doi.org/10.1111/j.1521-0391.2003.tb00555.x","title":"Research Advances in the Understanding and Treatment of Addiction","display_name":"Research Advances in the Understanding and Treatment of Addiction","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2165220936","doi":"https://doi.org/10.1111/j.1521-0391.2003.tb00555.x","mag":"2165220936","pmid":"https://pubmed.ncbi.nlm.nih.gov/12857662"},"language":"en","primary_location":{"id":"doi:10.1111/j.1521-0391.2003.tb00555.x","doi":"https://doi.org/10.1111/j.1521-0391.2003.tb00555.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1521-0391.2003.tb00555.x","pdf_url":null,"source":{"id":"https://openalex.org/S134700381","display_name":"American Journal on Addictions","issn_l":"1055-0496","issn":["1055-0496","1521-0391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal on Addictions","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2165220936"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086354155","display_name":"Charles P. O\u2019Brien","orcid":"https://orcid.org/0000-0002-8206-9831","observed_orcids":["https://orcid.org/0000-0002-8206-9831"]},"institutions":[{"id":"https://openalex.org/I4210133394","display_name":"Philadelphia VA Medical Center","ror":"https://ror.org/03j05zz84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210133394","https://openalex.org/I4210147340"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Charles P. O'Brien","raw_affiliation_strings":["From the University of Pennsylvania, VA Medical Center, Philadelphia, Pa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Pennsylvania, VA Medical Center, Philadelphia, Pa","institution_ids":["https://openalex.org/I4210133394","https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5086354155"],"corresponding_institution_ids":["https://openalex.org/I4210133394","https://openalex.org/I79576946"],"apc_list":{"value":3920,"currency":"USD","value_usd":3920},"apc_paid":null,"fwci":3.8881,"has_fulltext":false,"cited_by_count":83,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93729562,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"12","issue":"2","first_page":"S36","last_page":"S47"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/addiction","display_name":"addiction","score":0.968999981880188},{"id":"https://openalex.org/keywords/relapse-management","display_name":"relapse management","score":0.6859999895095825},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9359999895095825},{"id":"https://openalex.org/keywords/acamprosate","display_name":"acamprosate","score":1.0},{"id":"https://openalex.org/keywords/pharmacological-treatment-of-addiction","display_name":"pharmacological treatment of addiction","score":0.843999981880188},{"id":"https://openalex.org/keywords/genetic-and-environmental-risk-factors","display_name":"genetic and environmental risk factors","score":0.7609999775886536},{"id":"https://openalex.org/keywords/medicine-availability","display_name":"drug availability","score":0.3610000014305115},{"id":"https://openalex.org/keywords/route-of-administration","display_name":"route of administration","score":0.6010000109672546},{"id":"https://openalex.org/keywords/personality","display_name":"personality","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.6320828199386597},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4373505711555481},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.399764746427536},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.3205808997154236},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.26920196413993835}],"mesh":[{"descriptor_ui":"D000077443","descriptor_name":"Acamprosate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000427","descriptor_name":"Alcohol Deterrents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1521-0391.2003.tb00555.x","doi":"https://doi.org/10.1111/j.1521-0391.2003.tb00555.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1521-0391.2003.tb00555.x","pdf_url":null,"source":{"id":"https://openalex.org/S134700381","display_name":"American Journal on Addictions","issn_l":"1055-0496","issn":["1055-0496","1521-0391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal on Addictions","raw_type":"journal-article"},{"id":"doi:10.1080/10550490390210092","doi":"https://doi.org/10.1080/10550490390210092","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10550490390210092","pdf_url":null,"source":{"id":"https://openalex.org/S134700381","display_name":"American Journal on Addictions","issn_l":"1055-0496","issn":["1055-0496","1521-0391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal on Addictions","raw_type":"journal-article"},{"id":"pmid:12857662","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12857662","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal on addictions","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W130544524","https://openalex.org/W1599251494","https://openalex.org/W1709379088","https://openalex.org/W1939011264","https://openalex.org/W1966533004","https://openalex.org/W1970483518","https://openalex.org/W1977436056","https://openalex.org/W1977914858","https://openalex.org/W1986911450","https://openalex.org/W2022235619","https://openalex.org/W2024374498","https://openalex.org/W2045284958","https://openalex.org/W2046983320","https://openalex.org/W2054785055","https://openalex.org/W2056671158","https://openalex.org/W2069072046","https://openalex.org/W2078920224","https://openalex.org/W2093559862","https://openalex.org/W2096049617","https://openalex.org/W2104538950","https://openalex.org/W2126502833","https://openalex.org/W2138742021","https://openalex.org/W2152962921","https://openalex.org/W2162097818","https://openalex.org/W2168373111","https://openalex.org/W2171592578","https://openalex.org/W2416314887","https://openalex.org/W6999656644"],"related_works":["https://openalex.org/W1569294042","https://openalex.org/W2044367989","https://openalex.org/W2141125149","https://openalex.org/W4255993802","https://openalex.org/W2338670674","https://openalex.org/W2125331471","https://openalex.org/W2953634173","https://openalex.org/W1977247384","https://openalex.org/W4243679153","https://openalex.org/W2468433872"],"abstract_inverted_index":{"The":[0],"likelihood":[1],"of":[2,10,22,27,31,37,54,62,65,71,82],"developing":[3],"an":[4],"addictive":[5],"disorder":[6],"is":[7,41,67],"a":[8],"function":[9],"multiple":[11],"simultaneous,":[12],"pharmacologic,":[13],"genetic,":[14],"and":[15,34,88,95],"environmental":[16],"variables,":[17],"such":[18,92],"as":[19,93],"the":[20,23,25,29,32,35,38,48,52,60,63],"pharmacology":[21],"drug,":[24],"route":[26],"administration,":[28],"personality":[30],"individual,":[33],"availability":[36],"drug.":[39],"There":[40],"increasing":[42],"evidence":[43],"that":[44,70],"long-lasting":[45],"changes":[46],"in":[47],"brain":[49],"result":[50],"from":[51],"progression":[53,64],"casual":[55],"user":[56],"to":[57,69],"addict.":[58],"Moreover,":[59],"course":[61],"addiction":[66],"similar":[68],"other":[72],"chronic":[73],"diseases.":[74],"In":[75],"this":[76],"paper,":[77],"strategies":[78],"for":[79],"effective":[80],"treatment":[81],"addiction,":[83],"including":[84],"long-term":[85],"relapse":[86],"management":[87],"new":[89],"pharmacological":[90],"therapies":[91],"naltrexone":[94],"acamprosate,":[96],"are":[97],"discussed.":[98]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2165220936","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
